×
Lantheus Holdings EBIT 2013-2025 | LNTH
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Lantheus Holdings ebit from 2013 to 2025. Ebit can be defined as earnings before interest and taxes.
View More
Lantheus Holdings EBIT 2013-2025 | LNTH
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Lantheus Holdings ebit from 2013 to 2025. Ebit can be defined as earnings before interest and taxes.
Related Stocks
Company Name
Market
Cap
Abbott Laboratories (ABT)
$215.2B
Boston Scientific (BSX)
$153.3B
Stryker (SYK)
$148.6B
EssilorLuxottica (ESLOY)
$131.1B
Medtronic (MDT)
$114.9B
Lonza Group Ag (LZAGY)
$49.8B
Haleon (HLN)
$43.1B
ResMed (RMD)
$37.8B
GE HealthCare Technologies (GEHC)
$34.8B
Agilent Technologies (A)
$32.4B
Terumo (TRUMY)
$23.9B
Koninklijke Philips (PHG)
$23.7B
Insulet (PODD)
$20B
Zimmer Biomet Holdings (ZBH)
$18.4B
Baxter (BAX)
$14.3B
Smith & Nephew SNATS (SNN)
$13.2B
Sunny Optical Technology (SNPTF)
$10.4B
Demant (WILYY)
$8.6B
Bio-Rad Laboratories (BIO)
$6.7B
Prestige Consumer Healthcare (PBH)
$3.7B
Perrigo (PRGO)
$3.7B
Haemonetics (HAE)
$3.5B
Shandong Weigao Medical Polymer (SHWGF)
$3.5B
Envista Holdings (NVST)
$3.3B
ICU Medical (ICUI)
$3B
LeMaitre Vascular (LMAT)
$1.8B
QuidelOrtho (QDEL)
$1.7B
AtriCure (ATRC)
$1.4B
Acuren (TIC)
$1.4B
AdaptHealth (AHCO)
$1.2B